Lewis A - Search Results

1

The effect of sodium-glucose co-transporter 2 inhibitors on outcomes after cardiac resynchronization therapy.

Bray JJH, Coronelli M, Scott SGC, Henry JA, Couch LS, Ahmad M, Ormerod J, Gamble J, Betts TR, Lewis A, Rider OJ, Green PG, Herring N. Bray JJH, et al. Among authors: lewis a. ESC Heart Fail. 2024 Apr 22. doi: 10.1002/ehf2.14784. Online ahead of print. ESC Heart Fail. 2024. PMID: 38649305 Free article.

2

An active fixation quadripolar left ventricular lead for cardiac resynchronization therapy with reduced postoperative complication rates.

Robertson C, Duffey O, Tang PT, Fairhurst N, Monteiro C, Green P, Grogono J, Davies M, Lewis A, Wijesurendra R, Ormerod J, Gamble J, Ginks M, Rajappan K, Bashir Y, Betts TR, Herring N. Robertson C, et al. Among authors: lewis a. J Cardiovasc Electrophysiol. 2022 Mar;33(3):458-463. doi: 10.1111/jce.15346. Epub 2022 Jan 11. J Cardiovasc Electrophysiol. 2022. PMID: 34968010 Free PMC article.

3

The effect of sodium-glucose cotransporter-2 inhibitors on inflammatory biomarkers: A meta-analysis of randomized controlled trials.

Buttice L, Ghani M, Suthakar J, Gnanalingham S, Carande E, Kennedy BWC, Pitcher A, Gamble JHP, Ahmad M, Lewis A, Jüni P, Rider OJ, Stephens JW, Bray JJH. Buttice L, et al. Among authors: lewis a. Diabetes Obes Metab. 2024 Apr 11. doi: 10.1111/dom.15586. Online ahead of print. Diabetes Obes Metab. 2024. PMID: 38602398

4

Structural and Metabolic Effects of Obesity on the Myocardium and the Aorta.

Rider OJ, Lewis AJ, Neubauer S. Rider OJ, et al. Obes Facts. 2014;7(5):329-338. doi: 10.1159/000368429. Epub 2014 Oct 23. Obes Facts. 2014. PMID: 25342107 Free PMC article.

5

Adverse right ventricular remodelling, function, and stress responses in obesity: insights from cardiovascular magnetic resonance.

Lewis AJM, Abdesselam I, Rayner JJ, Byrne J, Borlaug BA, Neubauer S, Rider OJ. Lewis AJM, et al. Eur Heart J Cardiovasc Imaging. 2022 Sep 10;23(10):1383-1390. doi: 10.1093/ehjci/jeab175. Eur Heart J Cardiovasc Imaging. 2022. PMID: 34453521 Free PMC article.

6

Retained Metabolic Flexibility of the Failing Human Heart.

Watson WD, Green PG, Lewis AJM, Arvidsson P, De Maria GL, Arheden H, Heiberg E, Clarke WT, Rodgers CT, Valkovič L, Neubauer S, Herring N, Rider OJ. Watson WD, et al. Circulation. 2023 Jul 11;148(2):109-123. doi: 10.1161/CIRCULATIONAHA.122.062166. Epub 2023 May 18. Circulation. 2023. PMID: 37199155 Free PMC article.

7

Pyruvate dehydrogenase as a therapeutic target for obesity cardiomyopathy.

Lewis AJ, Neubauer S, Tyler DJ, Rider OJ. Lewis AJ, et al. Expert Opin Ther Targets. 2016 Jun;20(6):755-66. doi: 10.1517/14728222.2016.1126248. Epub 2016 Jan 8. Expert Opin Ther Targets. 2016. PMID: 26617082 Review.

8

Cardiovascular magnetic resonance: at the heart of 21^st Century imaging.

Lewis AJM, Rider OJ. Lewis AJM, et al. Cardiovasc Diagn Ther. 2020 Jun;10(3):546-548. doi: 10.21037/cdt-20-577. Cardiovasc Diagn Ther. 2020. PMID: 32695634 Free PMC article. No abstract available.

9

The use of cardiovascular magnetic resonance for the assessment of left ventricular hypertrophy.

Lewis AJM, Rider OJ. Lewis AJM, et al. Cardiovasc Diagn Ther. 2020 Jun;10(3):568-582. doi: 10.21037/cdt.2020.01.14. Cardiovasc Diagn Ther. 2020. PMID: 32695638 Free PMC article. Review.

10

Use of cardiac magnetic resonance to detect changes in metabolism in heart failure.

Watson WD, Miller JJJ, Lewis A, Neubauer S, Tyler D, Rider OJ, Valkovič L. Watson WD, et al. Among authors: lewis a. Cardiovasc Diagn Ther. 2020 Jun;10(3):583-597. doi: 10.21037/cdt.2019.12.13. Cardiovasc Diagn Ther. 2020. PMID: 32695639 Free PMC article. Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

4,340 results

Search Page